BOTOX® Cosmetic Unveils “The One & Only” Campaign: A Celebration of Authenticity, Self-Expression, and Patient Stories A New Chapter for an Iconic Brand BOTOX® Cosmetic (onabotulinumtoxinA), one of the most…
Avanzanite Bioscience Strengthens Leadership with Appointment of Dr. Mark Bechter as Senior Vice President of Medical Affairs Avanzanite Bioscience B.V., a rapidly expanding European specialty pharmaceutical company dedicated to improving…
Alnylam Pharmaceuticals Prices Upsized $575 Million Convertible Senior Notes Offering, Strengthening Balance Sheet and Advancing Growth Strategy Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a recognized global leader in RNA interference (RNAi)…
France Grants Reimbursed Compassionate Access for Agenus’ Botensilimab plus Balstilimab in Refractory MSS Metastatic Colorectal Cancer In a significant development for patients with advanced colorectal cancer, Agenus Inc. (Nasdaq: AGEN),…
Cascade Bio Secures $6 Million to Advance Biocatalyst Innovation and Transform Biomanufacturing In a world grappling with climate change, supply chain disruptions, and the growing demand for sustainable manufacturing, biotechnology…
Nuvig Therapeutics Strengthens Leadership Team with Appointment of David J. Woodhouse, Ph.D., as Chief Executive Officer and James Mackay, Ph.D., as Independent Board Chair Nuvig Therapeutics, Inc. (“Nuvig”), a privately…
RION Launches INTENT Biologics to Advance Late-Stage Clinical Exosome Therapies in Inflammation & Immunology; Appoints Industry Leader Suneet Varma as CEO RION, a clinical-stage regenerative medicine company recognized globally for…
Evonik and Ethris Forge Strategic Alliance to Redefine Nucleic Acid Delivery with Novel Lipid Nanoparticle Platform In a move that underscores the rapid evolution of nucleic acid-based medicines and the…
CyPath® Lung Demonstrates Diagnostic Power in Detecting Cancer Within Ground-Glass Nodules: A Case Study Highlighting bioAffinity Technologies’ Advancements in Noninvasive Lung Cancer Detection Lung cancer remains one of the deadliest…
Corner Therapeutics Research Opens Door to Universal Flu Vaccine and Expands Promise for Cancer Immunotherapy Corner Therapeutics, a biotechnology company specializing in in vivo T cell modulation and immunotherapy, has…
Alnylam Pharmaceuticals Launches $500 Million Convertible Senior Notes Offering to Strengthen Strategic Flexibility and Advance RNAi Pipeline Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the biotechnology pioneer recognized worldwide as the leader…
JCR Pharmaceuticals Showcases Landmark Five-Year Clinical Data on Pabinafusp Alfa at ICIEM 2025, Reinforcing Transformative Potential for Patients with Hunter Syndrome and Expanding Pipeline of Brain-Penetrant Enzyme Replacement Therapies In…